The announcement comes just two weeks after Merck pulled its painkiller, Vioxx, which is in the same class of drugs as Bextra, from the market because a study showed that the risk of heart attacks doubled for patients who had taken Vioxx for 18 months or longer.
Merck & Co. removed Vioxx from use Thursday after new study results showed increased risk of heart attacks and stroke in people.
Vioxx was approved after trials showed it to be effective.
Data from a company study.
Pfizer says there is no evidence that its drugs have problems similar to Vioxx.
